63262-66-8

Basic information

• Product Name: Cyclohexanemethanol, 2-hydroxy-, a-(4-methylbenzenesulfonate), trans-
• CAS NO: 63262-66-8
• Molecular Formula: C14H20O4S
• Molecular Weight: 284.376
• Mol File: 63262-66-8.mol

Chemical Properties

• CAS DataBase Reference: Cyclohexanemethanol, 2-hydroxy-, a-(4-methylbenzenesulfonate), trans-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanemethanol, 2-hydroxy-, a-(4-methylbenzenesulfonate), trans-(63262-66-8)
• EPA Substance Registry System: Cyclohexanemethanol, 2-hydroxy-, a-(4-methylbenzenesulfonate), trans-(63262-66-8)

Safety Data

• Hazardous Substances Data: 63262-66-8(Hazardous Substances Data)

Upstream product

• 4187-59-1 trans-2-hydroxymethylcyclohexanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 1655-06-7 (1R,2S)-ethyl 2-hydroxycyclohexanecarboxylate 
• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 
• 27583-43-3 2-(hydroxymethyl)cyclohexanol 

Downstream Products

• 62872-54-2 trans-2-(iodomethyl)cyclohexan-1-ol 
• 71771-35-2 2-p-nitrophenoxy-2-oxo-trans-5,6-tetramethylene-1,3,2-oxazaphosphorinane 
• 109087-14-1 trans-2-(aminomethyl)cyclohexanol 
• 75732-66-0 trans-2-(mercaptomethyl)cyclohexanol 

Relevant articles and documents

THE ANOMERIC EFFECT OF THE CARBOETHOXY GROUP IN OXYGEN AND SULPHUR CONTAINING HETEROCYCLES

The anomeric effect of the carboethoxy substituents and the ring oxygen in 1,3-dioxane- and 1,3-oxathiane-2-carboxylates has been estimated in low polar solvents by including empirical correlation factor α to be 4 kJ/mol.The conformational energies of the

HETEROARYL RHEB INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.

BIARYL PYRAZOLES AS NRF2 REGULATORS

The present invention relates to biaryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.